See All Slides - tctmd.com

Slides

Presentation TCT 2013

Risk/Benefit Favors: Medical Therapy First

Presenter: David Maron

October 28, 2013

Presentation TCT 2013

Epidemiology and Prognostic Impact of Mitral Regurgitation (and Why Does MR Take a Backseat to Aortic Stenosis?)

Presenter: Maurice Sarano

October 28, 2013

Presentation TCT 2013

The Thubrikar TAVR System

Presenter: Susheel Kodali

October 28, 2013

Presentation TCT 2013

PROTECT: Four-Year Results from a Prospective, Randomized Trial of Sirolimus-Eluting Stents and Zotarolimus-Eluting Stents

Presenter: Laura Mauri

October 28, 2013

Presentation TCT 2013

Yes! With Current DES and Pharmacotherapy, SYNTAX Is Already Obsolete and the Majority of Patients with MVD Can Be Managed with PCI

Presenter: Dean Kereiakes

October 28, 2013

Presentation TCT 2013

First Look: The MitrAssist Transcatheter Mitral Valve

Presenter: Peter Fitzgerald

October 28, 2013

Presentation TCT 2013

Managing Carotid Stent Complications

Presenter: Leo Nelson Hopkins

October 28, 2013

Presentation TCT 2013

Perspectives on the Role of Primary and Secondary Mitral Regurgitation in Heart Failure: Diagnosis and Management Algorithms

Presenter: Jeffrey Borer

October 28, 2013

Presentation TCT 2013

Do I Really Need Bioresorbable Scaffolds in Germany?

Presenter: Bernhard Witzenbichler

October 28, 2013

Presentation TCT 2013

Long-term Patency Is Essential Following BTK Intervention for Limb Salvage!

Presenter: Thomas Zeller

October 28, 2013

Advertisement

Slides

Risk/Benefit Favors: Medical Therapy First

Epidemiology and Prognostic Impact of Mitral Regurgitation (and Why Does MR Take a Backseat to Aortic Stenosis?)

The Thubrikar TAVR System

PROTECT: Four-Year Results from a Prospective, Randomized Trial of Sirolimus-Eluting Stents and Zotarolimus-Eluting Stents

Yes! With Current DES and Pharmacotherapy, SYNTAX Is Already Obsolete and the Majority of Patients with MVD Can Be Managed with PCI

First Look: The MitrAssist Transcatheter Mitral Valve

Managing Carotid Stent Complications

Perspectives on the Role of Primary and Secondary Mitral Regurgitation in Heart Failure: Diagnosis and Management Algorithms

Do I Really Need Bioresorbable Scaffolds in Germany?

Long-term Patency Is Essential Following BTK Intervention for Limb Salvage!

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content